Introduction
============

*Euphorbia* (Euphorbiaceae) is a very large and diverse genus of flowering plants comprising of about 2,000 members and is found all over the world, ranging from short annual plants to well developed tall trees \[[@R1]\].

The plants of the family Euphorbiaceae contain well-known skin irritating and tumor-promoting diterpenoids with tigliane, ingenane and daphnane skeletons \[[@R2]\]. Some of the species are used in folk medicine to cure skin diseases, gonorrhea, migraines, intestinal parasites, and warts \[[@R3]\] and as a purgative \[[@R4]--[@R6]\]. Several macrocyclic diterpenoids with antibacterial, anticancer, anti-multidrug-resistant, antifeedant, anti-HIV and analgesic activity have been isolated from different *Euphorbia* species. They include jatrophane, ingol and myrsinane diterpenoids \[[@R7]--[@R13]\].

Triterpenoids which have been reported from various species of *Euphorbia* include β-amyrin \[[@R1]\], β-amyrin acetate \[[@R14],[@R18]\], cycloeucalenol, obtusifoliol, 24-methylenecycloartan-3-β-ol, β-sitosterol, betulin, erythrodiol, oleanolic acid, β-sitosterol glucoside\[[@R15]\], 29-norcycloart-5-ene-5,8-lanostadiene-3β-ol, 3β,24*S*,25-trihydroxycycloartane, 3β,24(*R*),25-trihydroxy-cycloartane, 24-methylenecycloartan-3β-ol \[[@R16]\], cycloart-23-ene-3,5-diol \[[@R17]\], lupeol, lupeol acetate, ginnone, ambrein, lupeone \[[@R18]\], 24-methylenecycloartanol \[[@R19]\], cycloart-25-en-3β,24-diol \[[@R20]\] and cycloart-22-ene-3β,25-diol \[[@R21]\]. In addition, nor-isoprenoids and coumarins have also been reported from few species of *Euphorbia* \[[@R22]--[@R24]\].

*Euphorbia geniculata* Orteg. \[[@R25]--[@R26]\], is a wild weed found in the Jammu region of India \[[@R27]\]. The plant is locally used for the treatment of bacterial infections and inflammations. Previous phytochemical investigations have demonstrated that this plant contains flavonoids: kaempferol, quercetin and 3-rhamnosyl quercetin \[[@R28]\] and triterpenes β-amyrin acetate \[[@R29]\] and geniculatin \[[@R30]\].

Reinvestigation of chemistry of the plant led to isolation of three new triterpenoids, designated as genicunolide A (**1**), B (**2**) and C (**3**), together with friedelin (**4**) \[[@R31]\] and friedelinol (**5**) \[[@R32]\], from the ethyl acetate extract of the aerial parts of the plant. Herein, we report the characterization of the three compounds by spectral and chemical methods.

Results and Discussion
======================

The compounds **1**--**3** ([Fig. 1](#F1){ref-type="fig"}) responded positively to the characteristic Liebermann--Burchard \[[@R33]\], TCA \[[@R34]--[@R35]\] and TNM tests \[[@R35]\] for unsaturated triterpenoids.

![Structures of compounds **1**, **2**, **3**, **1a**, **2a**, **1b**, **2b**, **3a**, **4** and **5**.](Beilstein_J_Org_Chem-11-2707-g002){#F1}

The compound **1**, M^+^ at *m*/*z* 498.0695 (calculated for C~32~H~50~O~4~, 498.0700), possessed eight tertiary methyl groups, an acetoxy functionality \[*ν* *~max~* 1736 cm^−1^, δ 2.03 (s, 3H), δ~C~ 170.2, 21.3\], a trisubstituted double bond \[*ν* *~max~* 1630, 1042, 880 cm^−1^, δ 5.56 (d, *J* = 5.2 Hz, 1H, H-15)\] \[[@R36]\] and a secondary equatorial hydroxy group \[ν~max~ 3500 cm^−1^\] whose carbinylic proton resonated at δ 3.16 (dd, *J* = 8.1 Hz, 1H, H-3). On acetylation with Ac~2~O--C~5~H~5~N, at room temperature, compound **1** afforded the diacetate **1a**, δ 2.06 (s, 6H), and on oxidation with CrO~3~--C~5~H~5~N yielded a ketoacetate **1b**, ν~max~ 1738, 1680 cm^--1^, δ~C~ 216.7, 170.8, which responded positively to the characteristic Zimmermann test for 3-keto function \[[@R37]\], thereby placing the hydroxy group in compound **1** at 3β position, δ~C~ 77.2 \[[@R38]\].

The mass spectrum of compound **1** displayed the characteristic features of the taraxer-14-ene skeleton \[[@R39]\] by exhibiting RDA fragment ion peaks at *m*/*z* 374 (rings A/B/C) and 124 (ring E) and the vinylic carbon resonance signals at δ~C~ 118.8 (C-15) and 157.0 (C-14) \[[@R40]\].

The presence of a *cis*-oxido functionality in compound **1** was evident from a pair of AB doublets at δ 2.82 and 3.01 (*J* ~ae~ = 4.7 Hz, 1H each, H~e~-12 and H~a~-11), in its ^1^H NMR spectrum, two methine carbon resonance signals at δ~C~ 53.4 (C-11) and 58.3 (C-12) \[[@R41]\] and loss of CO and H~2~O, via rearrangement of hydrogen \[[@R42]\] from the RDA fragment ion at *m*/*z* 374 to give abundant ion peaks at *m*/*z* 346 and 354, respectively.

The acetoxy functionality in compound **1** was placed at C-1 β-position on the basis of the chemical shift, multiplicity and coupling constant of the carbinylic proton \[δ 4.53 (dd, *J* ~ae~ = 7.4 Hz, *J* ~aa~ = 8.5 Hz, 1H, H-1)\] together with the identical chemical shift of H-1 and H-3, in the ^1^H NMR spectrum of **1a**, and the comparable chemical shifts of C-1 and C-3 of **1a** (δ~C~ 80.7 and 80.6, respectively) with that of 1β,3β-diacetoxylupenes \[[@R43]\].

The structure of compound **1** was further confirmed by ^1^H,^1^H and ^1^H,^13^C COSY, HMBC and HSQC experiments which allowed unambiguous fixation of protons to appropriate carbons and also ^13^C-chemical shifts ([Table 1](#T1){ref-type="table"}). The long range correlations between the protons at δ 1.96 (H~a~-2) and 1.98 (H~e~-2) and carbonyl signal at δ~C~ 170.8 confirmed the presence of acetoxy carbonyl at C-1. This was further substantiated by the long range mutual coupling of the carbinylic proton at δ 4.53 with the proton at δ 3.16 as also with the carbon at δ~C~ 41.1 ppm (C-4). The correlation cross peaks between H-23 and H-25 and H-2 in the NOESY experiment confirmed that the acetoxy function at C-1 was β-oriented. The proton at δ 2.82 was correlated to the olefinic carbon at δ~C~ 157 ppm (C-14), three bonds away and allowed joining of spin systems separated by a methyl-bearing quaternary carbon on one side. The chemical shifts, multiplicity and coupling constants of the A-ring carbinylic protons and an inspection of the molecular models suggested that 1,3-*cis*-diequatorial functions in ring A caused flattening of this ring.

###### 

^13^C NMR data of **1**, **2**, **3** and their acetates in CDCl~3~ (δ in ppm, 125 MHz).

  -------- ------------- ------------- ------------- ------------- ------- -------------
  C        **1**         **1a**        **2**         **2a**        **3**   **3a**
                                                                           
  1        80.6          80.7          80.9          80.9          21.5    21.5
  2        27.8          29.8          29.9          29.7          28.6    29.0
  3        77.2          80.6          80.6          80.8          71.8    80.5
  4        41.1          41.5          41.1          41.3          41.9    42.0
  5        54.5          54.6          54.6          54.6          140.7   139.0
  6        18.4          19.5          19.5          20.1          121.7   122.0
  7        33.3          30.2          30.2          30.2          23.5    23.4
  8        39.6          39.9          39.6          40.1          42.7    42.9
  9        52.6          52.7          52.6          52.8          89.5    89.5
  10       37.6          38.1          37.6          38.1          42.7    42.8
  11       53.4          53.4          53.4          53.3          23.4    23.5
  12       58.2          58.3          58.2          58.4          26.4    26.4
  13       36.5          36.4          36.4          36.4          39.7    39.8
  14       157.1         157.1         157.2         157.1         36.9    37.0
  15       118.9         118.9         118.9         118.8         33.9    34.0
  16       35.7          35.9          35.7          35.8          31.9    31.8
  17       35.4          35.8          35.8          35.8          32.3    32.5
  18       48.1          48.5          48.1          48.6          56.1    56.3
  19       40.2          42.1          41.5          42.1          46.2    46.1
  20       28.7          28.8          31.9          27.5          77.2    77.3
  21       35.7          35.9          77.2          80.1          31.9    42.5
  22       35.6          35.7          39.6          35.1          42.7    42.5
  23       27.0          27.1          27.0          27.2          31.9    31.8
  24       17.0          16.5          16.7          16.7          29.3    29.5
  25       16.6          16.5          16.5          27.5          20.3    20.3
  26       27.0          27.5          27.8          30.1          19.8    19.9
  27       30.2          30.2          30.2          29.8          12.1    12.3
  28       29.9          29.8          29.9          29.9          23.1    23.2
  29       33.6          33.1          33.3          33.3          20.0    20.1
  30       19.5          19.5          19.5          19.5          36.1    36.2
  1-OAc    170.8, 21.3   170.7, 21.2   170.8, 21.1   170.8, 21.1   --      --
  3-OAc    --            170.9, 21.4   170.9, 21.2   170.9, 21.2   --      170.5, 21.4
  21-OAc   --            --            --            170.1, 21.3   --      --
  -------- ------------- ------------- ------------- ------------- ------- -------------

The spectral patterns of compound **2**, M^+^ at *m*/*z* 556.0739, C~34~H~52~O~6~, resembled closely with those of **1a**, except that it was shown to possess an extra secondary hydroxy group \[*ν* *~max~* 3350 cm^--1^, δ 3.17 (dd, *J* = 11.1 Hz, 1H)\]. Its presence was confirmed by acetylation of **2** to **2a** \[δ 2.05 (s, 9H), δ~C~ 170.1, 170.7 and 170.8\] and oxidation to diacetoxy ketone **2b** \[*ν* *~max~* 1736, 1730, 1680 cm^--1^, δ~C~ 170.5, 170.6, 215.2 (C-21)\]. The mass spectrum of compound **2** exhibited RDA fragment ions at *m*/*z* 416 and 140, placing the hydroxy group in ring E. The hydroxy group was placed at C-21 α-position (δ~C~ 77.2) \[[@R38]\] on the basis of coupling constant of carbinylic proton in the ^1^H NMR spectrum of **2**, the downfield chemical shift of C-30 methyl protons (δ 1.09) in the spectrum of **2b**, and ^1^H,^1^H, ^1^H,^13^C COSY, HMBC and HSQC spectra of **2** which showed long range correlations of the carbinylic proton at δ 3.17 (H-21) and methyl protons at δ 0.87 (H-29) as also carbons at δ~C~ 35.7 (C-16) and 48.1 (C-18).

The ^1^H NMR, ^13^C NMR ([Table 1](#T1){ref-type="table"}) and DEPT (135°) spectra of compound **3**, M^+^ at *m*/*z* 458.1495, C~30~H~50~O~3~, revealed that the compound possesses seven tertiary methyls, one of which resonated downfield at δ 1.53; a secondary methyl \[δ 0.85 (d, *J* = 4.2 Hz, 3H)\], a trisubstituted double bond \[ν~max~ 1640, 1040, 890 cm^−1^, δ 5.36 (d, *J* = 4.7 Hz, 1H)\], and a secondary hydroxy group \[ν~max~ 3465 cm^−1^, δ 3.52 (dd, *J* ~aa~ = 7.6 Hz, H-3, 1H)\]. On acetylation with Ac~2~O--C~5~H~5~N, at room temperature, it afforded monoacetate **3a** \[1735, δ 2.05 (s, 3H), δ~C~ 170.5\] and on oxidation with CrO~3~--C~5~H~5~N, it yielded a ketone which gave a positive Zimmermann test for 3-keto group \[[@R37]\] confirming the presence of the C-3 equatorial secondary hydroxy group \[δ~C~ 71.8\] in **3**. The mass spectrum of compound **3** revealed that the double bond triggered the typical RDA fragmentation of ring B \[[@R39]\] to give densely populated ion peaks at *m*/*z* 166 (ring A) and 292 (rings C/D/E) placing the double bond at C-5 \[δ~C~ 122.0 (C-6), 139.9 (C-5)\] \[[@R38]\] and two hydroxy groups in rings C/D/E. Since the monoacetate **3a** still retained a hydroxy group and its mass spectrum also showed a RDA fragment ion at *m*/*z* 292, compound **3**, therefore, carried two tertiary hydroxy groups on rings C/D/E. The presence of a secondary methyl group together with a pair of doublets at δ 1.56 and 1.85 (d br, *J* = 10.0 Hz, 1H each, H-18 and H-19) showed that the compound belonged to the Ψ-taraxastane \[[@R35]\] series. The downfield shift of C-30 methyl singlet (δ 1.53) suggested that one of the tertiary hydroxy groups was at C-20 (δ~C~ 77.3). Had it been on C-19, the ^13^C signal would have been observed upfield at δ~C~ 73.0--73.2 \[[@R44]\]. The densely populated ion peaks at *m/z* 221 (rings A/B) and 203 (221 − H~2~O**^.^** ^+^), arising from the fission of 9, 11 and 8, 14 bonds in ring C, together with the downfield carbon signal at δ~C~ 89.5 placed the second tertiary hydroxy groups at C-9. The structure of compound **3** was further confirmed by ^1^H,^1^H, ^1^H,^13^C COSY and long range ^1^H,^13^C COSY experiments. The presence of the C-9 hydroxy group was proved by linking the carbon signal at δ~C~ 89.5 to proton signals at δ 1.01 (C-25) and 0.93 (C-26) in the ^1^H,^13^C long-range coupled spectrum. Other data for 1D and 2D NMR spectra of **3** were in agreement with the assigned structure.

Comparison of physical characteristics and spectral data of compounds **4** and **5**, with those reported in literature \[[@R31]--[@R32]\], confirmed them to be friedelin and friedelinol, respectively.

Conclusion
==========

The compounds **1**--**5** were, thus, characterized as 1β-acetoxy-3β*-*hydroxy-11α,12α-oxido-taraxer-14-ene (**1**); 1β,3β-diacetoxy-21α-hydroxy-11α,12α-oxido-taraxer-14-ene (**2**); 3β,9α,20α-trihydroxy-Ψ-taraxast-5-ene (**3**); friedelin (**4**) and friedelinol (**5**); respectively. Compounds **1**--**3** are new triterpenoids while **4** and **5** appear to have been isolated for the first time from the genus *Euphorbia*.

Experimental
============

General procedures
------------------

Melting points were determined in centigrade scale in one end open capillaries on a Büchi 570 melting point apparatus and are uncorrected. IR spectra were recorded on a Perkin-Elmer Paragon-1000 spectrophotometer or an Esquire 3000 spectrometer. ^1^H and ^13^C NMR spectra were recorded by a Bruker 500 and 125 MHz instrument using TMS as internal standard and CDCl~3~ as solvent. High-resolution mass spectra were recorded on a Bruker 400 mass spectrometer. Column chromatography was carried out with Merk silica gel (60--120 mesh). Optical rotation was measured on a Perkin-Elmer polarimeter.

Plant material
--------------

The aerial parts of *Euphorbia geniculata* (Orteg) were collected from Jammu, (J&K, India) in July 2013. The specimen was identified by Akhtar H. Malik, Curator, Centre for Biodiversity & Taxanomy, University of Kashmir (Specimen deposited under accession No. 1850 -- KASH Herbarium).

Extraction and isolation
------------------------

The shade dried aerial parts of *Euphorbia geniculata* (3.0 kg) were extracted sequentially with petroleum ether (60--80 °C), ethyl acetate and methanol in a soxhlet apparatus to afford respective extracts which were concentrated under reduced pressure. The ethyl acetate extract (40 g) was subjected to chromatography on silica gel (60--120 mesh, B.D.H.) column using graded solvent systems of petroleum ether--ethyl acetate. The fractions collected with petroleum ether--ethyl acetate (9:1), F-1; (8:2), F-2; (7:3), F-3 and ethyl acetate, F-4, whose components gave green, pink and violet colouration on TLC (silica gel G) plates, after development with cerric ammonium sulfate--H~2~SO~4~, were subjected to re-chromatography. The fraction F-1 on re-chromatography and elution with petroleum ether--dichloromethane (8:2) gave **4** (300 mg) and **5** (410 mg). The fraction F-2 on further chromatography and elution with petroleum ether--dichloromethane (7:3) and (8:4) gave two mixtures. The mixture obtained with petroleum ether--dichloromethane (8:4) was subjected to preparative TLC using petroleum ether--chloroform (19:3) as solvent system to get compound **1** (48 mg). The fraction F-3 on further chromatography and elution with petroleum ether--dichloromethane (8:2) gave compound **2** (45 mg). The fraction **F-4** on repeated chromatography using the same sequence of graded solvent systems, as for crude extract, gave compound **3** (38 mg) with petroleum ether--dichloromethane (3:7) and a mixture containing **3** and **2**, which was again resolved by preparative TLC using benzene--ethyl acetate (9:1) as solvent system.

**Genicunolide A (1):** Colourless crystals (CHCl~3~--Me~2~CO), mp 150 °C; \[α\]~D~ ^25^ +20.5° (*c* 0.50, CHCl~3~); HRMS: *m*/*z* (rel. int.) 498.0695 (18) (M^+^) (calcd for C~32~H~50~O~4~, 498.0700), 483 (36.2), 480 (21.4), 456 (28.6), 441 (47.1), 374 (71.3) (RDA, rings A/B/C), 346 (57.2), 314 (42.7), 124 (65.8) (RDA, ring E), 108 (100); IR: ν~max~ 3500 (OH), 3030, 2850, 1736 (OAc), 1630, 1456, 1042, 880 cm^−1^; ^1^H NMR (500 MHz, CDCl~3~) δ 0.80 (s, 3H, H-28), 0.86 (s, 6H, H-24, H-29), 0.89 (s, 3H, H-30), 0.90 (s, 3H, H-23), 1.01 (s, 3H, H-25), 1.09 (s, 3H, H-26), 1.25 (s, 3H, H-27), 2.06 (s, 3H, OCOCH~3~), 2.31 (d, *J* = 6.9 Hz, 2H, H-16), 2.82 (d, *J* = 4.7 Hz, 1H, H-12), 3.01 (d, *J* = 4.7 Hz, 1H, H-11), 3.16 (dd, *J* = 5.5, 8.1 Hz, 1H, H-3), 4.53 (dd, *J* = 7.4, 8.5 Hz, 1H, H- 1), 5.56 (d, *J* = 5.2 Hz, 1H, H-15); ^13^C NMR: [Table 1](#T1){ref-type="table"}.

**Genicunolide B (2):** Colourless crystals (CHCl~3~--Me~2~CO), mp 160 °C, \[α\]~D~ ^25^ + 34.2° (*c* 0.40, CHCl~3~); HRMS: *m*/*z* 556.0739 (M^+^) (calcd for C~34~H~52~O~6~, 556.0744), 541 (M^+^ − **^.^**CH~3~), 514 (M^+^ − CH~2~CO), 472 (514 − CH~2~CO), 454 (472 − H~2~O), 416 (RDA, rings A/B/C), 356 (416 − HOAc), 286 (356 − CO − CH~2~CO), 140, 124 (RDA, ring E), 108 (124 -- H2O)(100); IR: ν~max~ 3550, 3025, 2863, 1736 (OAc), 1730 (OAc), 1625, 1450, 1045, 890 cm^−1^; ^1^H NMR (500 MHz, CDCl~3~) δ 0.80 (s, 3H, H-28), 0.87 (s, 6H, H-24, H-29), 0.97 (s, 3H, H-30), 0.98 (s, 3H, H-23), 1.01 (s, 3H, H-25), 1.09 (s, 3H, H-26), 1.25 (s, 3H, H-27), 2.06 (s, 6H, 2 x OAc), 2.31 (s, 2H, H-16), 2.80 (d, *J* = 4.7 Hz, 1H, H-12), 3.01 (d, *J* = 4.8 Hz, 1H, H-11), 3.17 (dd, *J* = 5.5, 11.1 Hz, 1H, H-21), 4.53 (dd, *J* = 7.6, 8.5 Hz, 2H, H~a~-1, H~a~-3), 5.56 (d, *J* = 5.2 Hz, 1H, H-15); ^13^C NMR: [Table 1](#T1){ref-type="table"}.

**Genicunolide C (3):** Colourless needles, mp 210--211 °C, \[α\]~D~ ^25^ +30.3° (*c* 0.3, CHCl~3~); HRMS: *m*/*z* 458.1495 (M**^.^** ^+^) (calcd for C~30~H~50~O~3~, 458.1500) (M**^.^** ^+^), 443 (M^+^ − CH~3~), 440 (M^+^ − H~2~O), 425 (M^+^ − CH~3~ − H~2~O), 413 (M^+^ − CH~3~CH=^+^OH), 292 (RDA, rings C/D/E), 237 (RDA, rings D/E), 221, 203, 166 (RDA, ring A), 163, 107, 83, 45 (100); IR: *ν* *~max~* 3580, 3465, 1640, 1445, 1040, 1025, 890 cm^−1^; ^1^H NMR (500 MHz, CDCl~3~) δ 0.68 (s, 3H, H-28), 0.79 (s, 3H, H-27), 0.81 (s, 3H, H-23), 0.85 (d, *J* = 4.2 Hz, 3H, H-29), 0.90 (s, 3H, H-24), 0.93 (s, 3H, H-26), 1.01 (s, 3H, H-25), 1.53 (s, 3H, H-30), 1.56 (d br, *J* = 10.0 Hz, 1H, H-18), 1.85 (d br, *J* = 10.0 Hz, 1H, H-19), 2.28 (s, 2H, H-7), 3.52 (dd, *J* = 4.8, 7.6 Hz, 1H, H-3), 5.36 (d, *J* = 4.7 Hz, 1H, H-6); ^13^C NMR: [Table 1](#T1){ref-type="table"}.

**Acetylation of 1, 2 and 3:** Compounds **1, 2** and **3** (20 mg each) were dissolved separately in C~5~H~5~N (2 mL) and Ac~2~O (2 mL) was added. The reaction mixtures were left overnight, diluted with water and extracted with chloroform. The chloroform solutions were washed with 5% HCl--H~2~O solution (10 mL each time) and dried over anhydrous K~2~CO~3~. After removal of the solvent, the crude acetates were purified by column chromatography on silica gel using petroleum ether--benzene (9:1, 7:3 and 1:1 v/v) when **1a**, **2a** and **3a** (18 mg, 17 mg and 19 mg, respectively) were recovered.

**Oxidation of 1 and 2:** Compound **1** (12 mg) and compound **2** (15 mg) were dissolved separately in C~5~H~5~N (1 mL) and treated with freshly prepared CrO~3~--C~5~H~5~N complex. The reaction mixtures were left overnight, diluted with water (10 mL) and extracted with chloroform (3 × 20 mL). The chloroform layer was washed with water, 0.1 N HCl, water and dried over anhydrous MgSO~4~. After removal of the solvent, the residues were purified by column chromatography over silica gel using a petroleum ether--benzene (1:1 v/v) solvent system, and crystallized from CHCl~3~--Me~2~CO.

Supporting Information
======================

###### 

Spectral data of genicunolide A acetate (**1a**), genicunolide B acetate (**2a**), genicunolide C acetate (**3a**), oxogenicunolide A (**1b**), oxogenicunolide B (**2b**), friedelin (**4**) and friedelinol (**5**).
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